Doxycycline hyclate (DOX), chemically known as (4S,4aR,5S,5aR,6R,12aS)-4-(dimethylamino)-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide hydrochloride hemiethanol hemihydrate (Fig. 1) , is one of the tetracycline derivatives, which has a wide range of antibacterial activities. DOX is frequently used to treat chronic prostatitis, sinusitis, syphilis, chlamydia, pelvic inflammatory disease, acne, rosacea, and rickettsial infections.
The literature contains several methods for the determination of DOX in pharmaceutical dosage forms, including liquid chromatography (2) , sequential injection chromatography (3) and capillary electrophoresis (4) . A few visible spectrophotometric methods based on the different reaction schemes are found in the literature for the assay of DOX. These include FIA-spectrophotometry with copper carbonate (5) and spectrophotometry based on colour reactions with thorium(IV) (6) , sodium cobaltnitrite (7) and uranyl acetate (8) . Besides, kinetic spectrophotometry using Cu(II)/H 2 O 2 (9) and multivariate calibration method (10) have also been reported by different authors.
Chromatographic techniques are the most widely used ones. Although these procedures are specific, most of the described methods are time consuming and require multistage extraction procedures. On the other hand, the reported spectrophotometric methods (5) (6) (7) (8) (9) (10) are for different reasons not satisfactory for the routine quality assurance. Some of these methods suffer from disadvantages such as poor sensitivity, low stability of the species, use of organic solvent, scrupulous control of experimental variables and special equipment (Table VII) .
Folin-Ciocalteu reagent (F-C) is widely used in the area of plant biology for analysis of polyphenols (11) and for the determination of many phenolic compounds in pharmaceuticals (12, 13) based on Folin-Ciocalteu reagent reduction. The present paper describes a reduction reaction involving F-C reagent and DOX resulting in the formation of a blue chromogen that could be measured at 770 nm.
EXPERIMENTAL

Instrument
A Systronic model 106 digital spectrophotometer (Systronics Ltd, India) with matched 1-cm quartz cells was used for absorbance measurements.
Chemicals and reagents
Chemicals used were of analytical grade. Distilled water was used throughout the investigation.
Folin-Ciocalteu reagent (Merck, India), sodium carbonate (S.D. Fine Chem Ltd, India) were of analytical reagent grade and used without further purification. A pure DOX (pharmaceutical grade) sample was kindly provided by Lotus Pharma Ltd, India. Three brands of tablets, namely, DOX-T 100 (Dr. Reddy's Lab, India), Microdox-DT and Doxy 100 (both from Micro Labs Ltd, India) were obtained from commercial sources. 
Drug and reagent solutions
A stock solution of DOX (300 mg mL -1 ) was prepared by dissolving pure DOX in water in a volumetric flask. Working concentration of DOX (30 mg mL -1 ) was prepared by dilution of the above stock solution with water.
The commercially available F-C reagent (defined as 2 eq L -1 ) was diluted with water in a ratio 1:1.
Absorption spectra
Pure DOX solution equivalent to 8.0 mg mL -1 was mixed with 3 mL of 1.4 mol L -1 Na 2 CO 3 and 2 mL of F-C reagent (1:1) in a 10-mL volumetric flask. After 20 min, the volume was made up to the mark with water and the content was mixed throughly. A blank solution was prepared in the same way in the absence of DOX. The blank was measured against water. Maximum absorbance was obtained at 770 nm and was fixed as analytical wavelength.
General analytical procedure
Different aliquots of the working standard DOX solution (30 mg mL -1 ), ranging from 0-4.0 mL, were transferred into a series of 10-mL volumetric flasks and the total volume was brought to 4.0 mL with water. To each flask, 3.0 mL of 1.42 mol L -1 Na 2 CO 3 and 2.0 mL of F-C reagent (1:1) solution were successively added by means of a microburette. The flasks were stoppered, contents were mixed and kept at room temperature for 20 min. The volume was made up to the mark with water and the absorbance of each solution was measured at 770 nm against a reagent blank.
Assay procedure for tablets
An amount of finely ground tablet powder equivalent to 3.0 mg of DOX was accurately weighed into a 100-mL volumetric flask, the flask was shaken after addition of a 70 mL of water for about 20 min and finally the volume was made up to the mark with water. The content was kept aside for 5 min, and filtered using Whatman No. 42 filter paper. The first 10-mL portion of the filtrate was discarded and a suitable aliquot was used for the assay as described under »General analytical procedure«.
Validation
Precision and accuracy. -For 3.0, 6.0 and 9.0 mg mL -1 of DOX, the assay described under the general analytical procedure was repeated seven times within a day to determine the repeatability (intra-day precision) and five times on different days to determine the intermediate precision (inter-day precision) of the method. Percentage relative error was evaluated between the measured mean concentration and the taken DOX concentration.
Recovery experiment was performed by applying the standard-addition technique. The recovery was assessed by determining the agreement between the measured con-centration and the added known concentration to the sample. The test was done by spiking the pre-analyzed tablet powder (4.16 mg mL -1 ) with pure DOX at three different levels (2.5, 5.0 and 7.5 mg mL -1 ) and the total was found by the proposed method. Each test was repeated three times.
Limits of detection (LOD) and quantification (LOQ). -The limits of detection (LOD)
and quantification (LOQ) were calculated according to ICH guidelines (14) using the formulae: LOD = 3.3 SD/b and LOQ = 10 SD/b, where SD is the standard deviation of blank absorbance values (n = 6), and b is the slope of the calibration line.
Selectivity. -A placebo blank of the composition: starch (10 mg), acacia (15 mg), hydroxyl cellulose (10 mg), sodium citrate (10 mg), talc (20 mg), magnesium stearate (15 mg) and sodium alginate (10 mg) was made and its extract was prepared as described under the assay procedure for tablets and then subjected to analysis.
To assess the role of inactive ingredients on the assay of DOX, the general procedure was followed by taking 4, 6 and 8 mg mL -1 DOX solution prepared using a synthetic mixture.
RESULTS AND DISCUSSION
The structural features of DOX allowed the use of F-C reagent for its assay. The proposed method is based on the formation of a blue colored chromogen when DOX reacted with the F-C reagent in the presence of sodium carbonate. Colour formation may be explained as follows based on the analogy reported by Peterson (15) DOX probably causes a reduction of molybdate in the F-C reagent, thereby producing one or more reduced species that have a characteristic intense blue colour. Fig. 2 shows the absorption spectra of the reaction product and reagent blank; under the same experimental conditions the blank had negligible absorbance.
Method development
Optimum conditions were fixed by varying one parameter at a time while keeping other parameters constant and observing their effect on the absorbance at 770 nm.
To find a suitable medium for the reaction different aqueous bases were investigated. Best results were obtained with sodium carbonate. It was found that maximum and constant absorbance was obtained in the concentration range of 0.28-0.57 mol L -1 Na 2 CO 3 , thus 0.43 mol L -1 was fixed as optimal.
It is apparent that ten to twenty-fold diluted F-C reagent produced maximum color intensity; F-C reagent at a dilution level of 1:20 was actually present in the reaction mixture.
The reaction time was studied by measuring the absorbance of the blue chromogen after mixing the reactants over a period from 2 min to 2 h. Maximum colour developed in 20 min and was stable for at least 60 min thereafter. Measurements were therefore made only after 20 min throughout the investigation.
Highest sensitivity was achieved when the order of reactants addition was maintained as described in the general analytical procedure and the same was followed throughout the investigation.
Validation
A linear correlation was found between absorbance at l max and DOX concentration in the range 0.75-12.0 mg mL -1 . Linear regression parameters within the Beer's law limits and molar absorptivity values of the method are given in Table I . Log absorbance versus log concentration plot yielded a straight line with the slope equal to 0.9922. The percentage relative standard deviation values were £ 1.6 % (intra-day) and £ 2.5 % (inter-day), indicating high precision of the method. Percent relative error of £ 2.7 % was evaluated. Results are summarized in Table II .
The percentage recovery values obtained were in the range from 98.9 to 103.6 %, with relative standard deviation 0.6-1.3 %. In all the cases, the results showed a fairly good accuracy of the method (Table III) .
A systematic study was performed to determine the effect of the matrix by analyzing the placebo blank. In the analysis of the placebo blank solution, the absorbance in each case was equal to the absorbance of reagent blank which revealed no interference.
The recovery values obtained in this study are presented in Table IV . The values of 97.4-104.3 % with RSD values of < 3 % clearly indicate non-interference of inactive ingredients in the assay.
In order to check the robustness of the method, the assay was performed using the same operational conditions but using different instruments in two different laboratories, different analysts and different elapsed times. The results obtained from inter-lab, inter-day and inter-analyst assays were reproducible. The inter-analyst RSD were within 2.5 % whereas the inter-instrument and inter-lab RSDs for the same DOX concentration were less than about 2.6 %. The results are presented in Table V. 450 Table II . Evaluation of intra-day and inter-day error and precision DOX taken (mg mL -1 ) Intra-day (n = 7)
Inter-day (n = 5) DOX found ± CL (mg mL -1 ) e R (%) RSD (%) DOX found ± CL (mg mL -1 ) e R (%) RSD (%) 103.6 ± 1.4
a Mean ± SD, n = 3.
Analysis of pharmaceutical formulations
The described procedure was successfully applied to the determination of DOX in pharmaceutical formulations. The results obtained were statistically compared with the official BP method (1) . The official method is liquid chromatography of DOX with UV detection at 350 nm. The results obtained by the proposed method agreed well with those of the reference method. The results were also compared statistically using Student's t-test for accuracy and a variance F-test for precision with those of the reference 451 The proposed method was found to be superior to the reported methods with respect to speed, simplicity, sensitivity and cost-effectiveness. It is less costly and it does not require expensive equipment, high-cost reagents or specialized technicians. In addition, it is free from extreme experimental or stringent conditions like heating at high temperature or extraction procedure (for comparasion see Table VII ). A new sensitive spectrophotometric method has been developed, optimized and validated for the determination of doxycycline in bulk drug and in tablets. The simplicity, sensitivity and selectivity make the method a suitable alternative to the HPLC methods. Other characteristics such as short performance time, ease of handling and non-usage of organic solvents, also suggest this procedure as a routine laboratory method. Therefore, the proposed method can be adopted for the assay of DOX in quality control laboratories where modern instruments are not available.
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